Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

• Sex differences in the prevalence of painful conditions appear after puberty • Variation in symptom severity across the menstrual cycle occurs in a number of clinical pain conditions • Sex steroid hormones act at a number of sites in both the peripheral and central nervous systems and in both reproductive and non-reproductive tissues • Sex steroid hormones have traditionally been thought to alter transcription; however, there is evidence that there are also non-genomic effects • Sex steroid hormones can have organisational effects from as early as in utero • The relationship between sex hormones and pain is complex

Original publication

DOI

10.1177/204946370800200206

Type

Journal article

Journal

Reviews in Pain

Publisher

SAGE Publications

Publication Date

12/2008

Volume

2

Pages

20 - 24